Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
5 pending office actions • 5 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready
ÅBO AKADEMI UNIVERSITY has 5 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are spread across 5 distinct examiners and 5 distinct art units, showing a high degree of diversification in the examination process. This distribution suggests that each matter is being handled by a different individual at the patent office.
KOVACH, KARA NICOLE is the busiest examiner for this university, currently overseeing 1 pending office action. Because there are 5 distinct examiners for the portfolio, the workload is evenly distributed across the 5 distinct art units. This structure implies that the Biotechnology & Pharmaceuticals filings cover a broad range of specific sub-disciplines, requiring the expertise of multiple specialized units.
The presence of 5 pending office actions indicates that ÅBO AKADEMI UNIVERSITY is engaging with a wide array of expertise. KOVACH, KARA NICOLE remains the busiest examiner with 1 pending office action, representing a single point of contact within this diverse prosecution landscape. This variety of examiners and art units ensures that each biological innovation is reviewed by a specialist in its specific field.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (20%) |
| §103 only | 1 (20%) |
| §112 only | 1 (20%) |
| Multi-statute (no §101) | 2 (40%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KOVACH, KARA NICOLE | 1 | 85.7% | +100.0% |
| DICKINSON, PAUL W | 1 | 63.2% | +9.6% |
| WORSHAM, JESSICA N | 1 | 56.6% | +56.4% |
| BABIC, CHRISTOPHER M | 1 | 60.6% | +23.6% |
| HON, SOW FUN | 1 | 57.6% | +64.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18838621 | Method for detecting and subtyping inflammatory intestinal diseases | KOVACH, KARA NICOLE | — |
| 18684198 | Bioactive mitochondria encapsulated in a metal organic framework | DICKINSON, PAUL W | — |
| 18575330 | Encapsulated biomolecules for intracellular delivery | WORSHAM, JESSICA N | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18838621 | Method for detecting and subtyping inflammatory intestinal diseases | KOVACH, KARA NICOLE | — |
| 18575330 | Encapsulated biomolecules for intracellular delivery | WORSHAM, JESSICA N | — |
| 18562473 | INSECT REPELLENT COMPOSITION AND A METHOD OF REPELLING INSECTS | BABIC, CHRISTOPHER M | — |
| 17785934 | Method of producing nanocellulose films | HON, SOW FUN | — |
| Art Unit | Apps |
|---|---|
| 1681 | 1 |
| 1618 | 1 |
| 1615 | 1 |
| 1633 | 1 |
| 1782 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18838621 | Method for detecting and subtyping inflammatory intestinal diseases | KOVACH, KARA NICOLE | 1681 | §101§102§103§112 | Non-Final OA | — | Pending | Aug 15, 2024 |
| 18684198 | Bioactive mitochondria encapsulated in a metal organic framework | DICKINSON, PAUL W | 1618 | §102§112 | Non-Final OA | — | Pending | Feb 16, 2024 |
| 18575330 | Encapsulated biomolecules for intracellular delivery | WORSHAM, JESSICA N | 1615 | §102§103§112 | Non-Final OA | — | Pending | Dec 29, 2023 |
| 18562473 | INSECT REPELLENT COMPOSITION AND A METHOD OF REPELLING INSECTS | BABIC, CHRISTOPHER M | 1633 | §103 | Final Rejection | — | Pending | Nov 20, 2023 |
| 17785934 | Method of producing nanocellulose films | HON, SOW FUN | 1782 | §112 | Non-Final OA | — | Pending | Jun 16, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialÅBO AKADEMI UNIVERSITY has 5 pending office actions as of October 2026, spread across 5 art units and 5 examiners.
Kara Nicole Kovach has the most, with 1 of ÅBO AKADEMI UNIVERSITY's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
